Company intelligence / Profile preview

Braindex

Loos, Hauts-de-France, Francebraindex.com ↗

Ownership: Private
Development stage: Commercial

Overview

Braindex has developed the ARGOS platform, a smart integrated brain sensor that allows clinicians to objectively assess the effects of anesthetic drugs on patients’ brains. The device provides real-time data using EEG and near-infrared spectroscopy (NIRS), enabling personalized anesthesia care. It is portable, non-invasive, suitable for all types of surgery, individualizes patient care, and aims to prevent postoperative delirium. The company is currently raising funds to expand clinical validation and commercialization efforts in both Europe and the US

Therapeutic areas: Neurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Region Hauts-de-FranceBpifranceEurasante

Beyond the preview

Go deeper on Braindex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Braindex.

Explore the full profile